• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Fistula - Pipeline Review, H1 2012 Product Image

Fistula - Pipeline Review, H1 2012

  • ID: 2141794
  • May 2012
  • 25 pages
  • Global Markets Direct

Fistula – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Fistula - Pipeline Review, H1 2012', provides an overview of the Fistula therapeutic pipeline. This report provides information on the therapeutic development for Fistula, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fistula. 'Fistula - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Fistula.
- A review of the Fistula products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Fistula Overview
Therapeutics Development
An Overview of Pipeline Products for Fistula
Fistula Therapeutics under Development by Companies
Fistula Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Fistula Therapeutics – Products under Development by Companies
Fistula Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Fistula Therapeutics Development
Fistula – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Pasireotide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adipoplus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adipose-Derived Stem Cells Without Expansion - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fistula Therapeutics - Dormant Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Fistula, H1 2012
Products under Development for Fistula – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
Fistula Therapeutics – Dormant Products

List of Figures
Number of Products under Development for Fistula, H1 2012
Products under Development for Fistula – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos